Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000004

Chief Medical Officer sold 7,000 shares at an average $31.81 ($222,704)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Goncalves Joana Chief Medical Officer 2026-01-15 Option exercise 10b5-1 +3,500 $6.84 $23,940 5,018 D
Goncalves Joana Chief Medical Officer 2026-01-15 Option exercise 10b5-1 +3,500 $7.80 $27,300 8,518 D
Goncalves Joana Chief Medical Officer 2026-01-15 Sale 10b5-1 −4,381 $31.56 $138,276 4,137 D
Goncalves Joana Chief Medical Officer 2026-01-15 Sale 10b5-1 −2,619 $32.24 $84,429 1,518 D
Derivatives
Goncalves Joana Chief Medical Officer 2026-01-15 Option exercise · Employee Stock Option (right to buy) 10b5-1 −3,500 221,563 D
Goncalves Joana Chief Medical Officer 2026-01-15 Option exercise · Employee Warrant (right to buy) 10b5-1 −3,500 192,992 D
Open-market sales · 7,000 sh · avg $31.81 · $222,704
Loading xslF345X05/form4.xml…